Issue · November 10, 2026
The Brief

Today's Ember
The early nineteen nineties, a dry cattle pasture in rural Zimbabwe. A young mother kneels beside a rock, folds a scrap of paper, pushes it into an old tin and buries it. On that paper are four dreams, and every one of them looks impossible.
Watch on The Morning Ember →
What's happening and what it means
Supreme Court lets Big Bend border wall construction resume
The Supreme Court on Monday stayed an Oct. 2 injunction that had halted border barrier construction in the Big Bend Sector of West Texas, over Justice Jackson's lone dissent. Work continues while the government seeks full review. The ruling narrows how anyone can challenge DHS's power to waive environmental and other laws for border construction: only a true constitutional claim counts, and "exceeded statutory authority" is not one. Barriers and patrol roads in the sector move ahead. Full story →
EstablishedPer curiam opinion, No. 26A560, Mullin v. Friends of the Ruidosa Church, 11/9: the government is "exceedingly likely to prevail" on its argument that the district court lacked jurisdiction; "There is no such thing as a 'constitutional' major-questions claim." The stay lasts until the court decides whether to hear the case. "Justice Jackson would deny the application for stay."
— Supreme Court per curiam opinion, 11/9
AttributedCBP Commissioner Rodney Scott has said the 30-foot wall will not cut through Big Bend National Park itself, though patrol roads and vehicle barriers would (CBS, 11/9). The plaintiffs, an environmental nonprofit, a river guide and a church-preservation group, argued that "once habitat is destroyed, vegetation cleared, historic resources damaged," the harm cannot be undone.
— CBS News, 11/9
UnknownWhether the government petitions for review and whether the court takes it; the stay ends automatically if review is denied. The majority did not rule on the waivers themselves.
California voters reject Prop 40 billionaire wealth tax
The Associated Press on Monday called Proposition 40 defeated. It would have imposed a one-time 5% tax on Californians worth more than $1 billion, with backers projecting up to $100 billion, mostly for Medi-Cal. California gets no new revenue to backfill federal Medicaid cuts, and the first statewide wealth-tax test failed in the country's most Democratic large state. A companion measure, Prop 42, which would bar future wealth taxes, was narrowly ahead. Full story →
EstablishedAP count reported by CalMatters, 11/9: No 52.8%, Yes 47.2% as of Monday evening; Prop 42 ahead 51.6% to 48.4%. Yes on 40 raised $33.5 million; opponents $378.4 million, including $102 million from Google co-founder Sergey Brin. Gov. Newsom opposed Prop 40 and endorsed Prop 42.
— CalMatters, 11/9; Al Jazeera, 11/10
AttributedSEIU-UHW president Dave Regan, 11/9, said the union will return in 2028 if the Legislature "fails to deliver a real solution" on health-care funding and called the opposition spending "incredibly corrosive and corrupting." No on 40 strategist Evan Westrop, 11/9, called the measure "a reckless experiment."
— CalMatters, 11/9
UnknownThe final margin; ballots are still being counted and Al Jazeera's 11/10 snapshot showed No at 55.6% with about 60% counted. Whether Prop 42 holds its lead, and how the state covers residents expected to lose Medi-Cal under federal cuts.
FDA orders vision-loss warning onto every GLP-1 drug
The FDA on Monday required makers of all 12 GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, to add a warning about NAION, a rare optic-nerve condition that can cause sudden, permanent vision loss in one eye. The drugs stay on the market and the FDA is not telling anyone to stop. The instruction is practical: sudden painless vision loss, blind spots or color distortion in one eye means call a doctor the same day. Full story →
EstablishedFDA Drug Safety Communication, 11/9: across 126 trials and 134,253 patients, NAION occurred at 6.4 per 100,000 person-years on GLP-1 drugs versus 3.8 on comparators (10 cases versus 5). The background rate in adults over 50 is 2.3 to 10.2 per 100,000. Prescribers should consider stopping the drug in patients who develop NAION "unless the benefits of treatment clearly outweigh the risk."
— FDA Drug Safety Communication, 11/9
AttributedNovo Nordisk said the data do not establish cause and effect and it remains confident in the drugs' benefit-risk profile; Eli Lilly said it is "carefully evaluating the update." Dr. Joseph Rizzo, co-author of the 2024 paper that prompted the review, said the evidence shows added risk but the drugs "have really been profoundly beneficial."
— CBS News, 11/9
UnknownWhether the link is causal: the FDA found no mechanism in animal data, and one of its two real-world comparisons showed no significant increase. Whether the warning changes prescribing or coverage.
Trump calls Iran war "effectively over" militarily; blockade stays
After meeting Qatar's prime minister Monday, Trump said "Iran militarily is effectively over" and the U.S. is keeping the "status quo," including the naval blockade. Iran's president said Iran "will not surrender to force and bullying." Gas averaged $4.01 Monday, down 36 cents in a month, and could drop under $4 this week because markets expect a deal. The blockade, Hormuz restrictions and missile attacks on Saudi Arabia are still in place, so that price can reverse quickly. Full story →
EstablishedTrump at the White House, 11/9, per CBS and Al Jazeera: "Iran militarily is effectively over"; "we're just keeping it the status quo"; the U.S. is "locked and loaded." AAA national average, 11/9: regular $4.009, versus $4.372 a month ago and $3.070 a year ago; diesel $6.17.
— CBS News live updates, 11/9; AAA, 11/9
AttributedQatar PM Sheikh Mohammed bin Abdulrahman Al Thani, on X, 11/9: "Grateful for the positive discussions on reaching a deal." Iran's foreign ministry, 11/9: any deal must lift sanctions and end the blockade. Secretary of State Rubio, 11/9: not "at the verge of a breakthrough"; Iran's demands are "unacceptable." Saudi-led coalition, 11/10: two missiles intercepted over Riyadh, blamed on the Houthis.
— Al Jazeera, 11/9 and 11/10; CBS News, 11/9
UnknownThe terms of the two-day proposal Qatar reportedly carried from Tehran, which are unpublished, and whether Washington accepts any of them. No end date for the blockade has been given; UAE adviser Anwar Gargash said Monday a full settlement is unlikely for "a long period."
How to read The Brief
Nobody's bias-free. Not the big outlets, not the "just the facts" newsletters, not us. So instead of promising clean news, we show our work. Every item carries three lines:
ESTABLISHED — backed by a primary document or independent confirmation.
ATTRIBUTED — somebody said it; we tell you exactly who and when. "The military reports a strike" is not "independent evidence confirms damage."
UNKNOWN — what's still unconfirmed. Five articles repeating one anonymous source is still one source.
One story. One brief. Every morning.
Get The Brief in your inbox before 8am.
Free. Unsubscribe any time.